“Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay

Abstract Background Mucopolysaccharidosis type I (MPS I) is a rare, recessively inherited lysosomal storage disorder, characterized by progressive multi‐systemic disease. It is caused by a reduced or absent alpha‐l iduronidase (IDUA) enzyme activity secondary to biallelic loss‐of‐function variants i...

Full description

Bibliographic Details
Main Authors: Amir Jahic, Sven Günther, Nicole Muschol, Barbro Fossøy Stadheim, Øivind Braaten, Hanne Kjensli Hyldebrandt, Gé‐Ann Kuiper, Karen Tylee, Frits A. Wijburg, Christian Beetz
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.615
id doaj-cec313b391b54b53b3d2c8c2a032f505
record_format Article
spelling doaj-cec313b391b54b53b3d2c8c2a032f5052020-11-25T01:58:49ZengWileyMolecular Genetics & Genomic Medicine2324-92692019-09-0179n/an/a10.1002/mgg3.615“Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assayAmir Jahic0Sven Günther1Nicole Muschol2Barbro Fossøy Stadheim3Øivind Braaten4Hanne Kjensli Hyldebrandt5Gé‐Ann Kuiper6Karen Tylee7Frits A. Wijburg8Christian Beetz9Institute of Clinical Chemistry and Laboratory Diagnostics Jena University Hospital Jena GermanyInstitute of Clinical Chemistry and Laboratory Diagnostics Jena University Hospital Jena GermanyDepartment of Pediatrics University Medical Center Hamburg‐Eppendorf Hamburg GermanyDepartment of Clinical Genetics Oslo University Hospital Oslo NorwayDepartment of Clinical Genetics Oslo University Hospital Oslo NorwayDepartment of Clinical Genetics Oslo University Hospital Oslo NorwayPediatric Metabolic Diseases Amsterdam UMC University of AmsterdamAcademic Medical Center (AMC) Amsterdam NetherlandsManchester Center for Genomic Medicine St Mary's Hospital Manchester UKPediatric Metabolic Diseases Amsterdam UMC University of AmsterdamAcademic Medical Center (AMC) Amsterdam NetherlandsInstitute of Clinical Chemistry and Laboratory Diagnostics Jena University Hospital Jena GermanyAbstract Background Mucopolysaccharidosis type I (MPS I) is a rare, recessively inherited lysosomal storage disorder, characterized by progressive multi‐systemic disease. It is caused by a reduced or absent alpha‐l iduronidase (IDUA) enzyme activity secondary to biallelic loss‐of‐function variants in the IDUA. Over 200 causative variants in IDUA have been identified. Nevertheless, there is a fraction of MPS I patients with only a single mutated IDUA allele detectable. Methods As genetic testing of MPS I is usually based on sequencing methods, copy number variations (CNVs) in IDUA can be missed and therefore presumably remain underdiagnosed. The aim of this study was the detection of CNVs using an IDUA‐specific in house multiplex ligation‐dependent probe amplification (MLPA) assay. Results A total of five unrelated MPS I patient samples were re‐analyzed after only a single heterozygous IDUA mutation c.979G>C (p.A327P), c.1469T>C (p.L490P), c.1598C>G (p.P533R), c.1205G>A (p.W402X), c.973‐7C>G (p.?) could be identified. We detected a novel splice site variant c.973‐7C>G (p.?), as well as two novel CNVs, a large deletion of IDUA exon 14 and 3’UTR c.(1828 + 1_1829‐1)_(*1963_?)del, and a large duplication extending from IDUA exon 2 to intron 12 c.(157 + 1_158‐1)_(1727 + 1_1728‐1)dup. Conclusion Together with the CNVs we previously identified, a total of four pathogenic IDUA CNVs have now been reported.https://doi.org/10.1002/mgg3.615copy number variationsdeletionduplicationIDUAMLPA
collection DOAJ
language English
format Article
sources DOAJ
author Amir Jahic
Sven Günther
Nicole Muschol
Barbro Fossøy Stadheim
Øivind Braaten
Hanne Kjensli Hyldebrandt
Gé‐Ann Kuiper
Karen Tylee
Frits A. Wijburg
Christian Beetz
spellingShingle Amir Jahic
Sven Günther
Nicole Muschol
Barbro Fossøy Stadheim
Øivind Braaten
Hanne Kjensli Hyldebrandt
Gé‐Ann Kuiper
Karen Tylee
Frits A. Wijburg
Christian Beetz
“Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
Molecular Genetics & Genomic Medicine
copy number variations
deletion
duplication
IDUA
MLPA
author_facet Amir Jahic
Sven Günther
Nicole Muschol
Barbro Fossøy Stadheim
Øivind Braaten
Hanne Kjensli Hyldebrandt
Gé‐Ann Kuiper
Karen Tylee
Frits A. Wijburg
Christian Beetz
author_sort Amir Jahic
title “Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
title_short “Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
title_full “Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
title_fullStr “Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
title_full_unstemmed “Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
title_sort “missing mutations” in mps i: identification of two novel copy number variations by an idua‐specific in house mlpa assay
publisher Wiley
series Molecular Genetics & Genomic Medicine
issn 2324-9269
publishDate 2019-09-01
description Abstract Background Mucopolysaccharidosis type I (MPS I) is a rare, recessively inherited lysosomal storage disorder, characterized by progressive multi‐systemic disease. It is caused by a reduced or absent alpha‐l iduronidase (IDUA) enzyme activity secondary to biallelic loss‐of‐function variants in the IDUA. Over 200 causative variants in IDUA have been identified. Nevertheless, there is a fraction of MPS I patients with only a single mutated IDUA allele detectable. Methods As genetic testing of MPS I is usually based on sequencing methods, copy number variations (CNVs) in IDUA can be missed and therefore presumably remain underdiagnosed. The aim of this study was the detection of CNVs using an IDUA‐specific in house multiplex ligation‐dependent probe amplification (MLPA) assay. Results A total of five unrelated MPS I patient samples were re‐analyzed after only a single heterozygous IDUA mutation c.979G>C (p.A327P), c.1469T>C (p.L490P), c.1598C>G (p.P533R), c.1205G>A (p.W402X), c.973‐7C>G (p.?) could be identified. We detected a novel splice site variant c.973‐7C>G (p.?), as well as two novel CNVs, a large deletion of IDUA exon 14 and 3’UTR c.(1828 + 1_1829‐1)_(*1963_?)del, and a large duplication extending from IDUA exon 2 to intron 12 c.(157 + 1_158‐1)_(1727 + 1_1728‐1)dup. Conclusion Together with the CNVs we previously identified, a total of four pathogenic IDUA CNVs have now been reported.
topic copy number variations
deletion
duplication
IDUA
MLPA
url https://doi.org/10.1002/mgg3.615
work_keys_str_mv AT amirjahic missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT svengunther missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT nicolemuschol missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT barbrofossøystadheim missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT øivindbraaten missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT hannekjenslihyldebrandt missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT geannkuiper missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT karentylee missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT fritsawijburg missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
AT christianbeetz missingmutationsinmpsiidentificationoftwonovelcopynumbervariationsbyaniduaspecificinhousemlpaassay
_version_ 1724967972570660864